Sanofi Aktie
87,03
EUR
-4,70
EUR
-5,12
%
87,31
EUR
-4,57
EUR
-4,97
%
Kursziele der Sanofi-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Sanofi-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| UBS AG | 115,00 EUR | +31,71% | 30.05.2025 | |
| JP Morgan Chase & Co. | 110,00 EUR | +25,99% | 30.05.2025 | |
| Jefferies & Company Inc. | 120,00 EUR | +37,44% | 28.05.2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 120,00 EUR | +37,44% | 16.05.2025 | |
| Deutsche Bank AG | 100,00 EUR | +14,53% | 28.04.2025 | |
| DZ BANK | - | - | 25.04.2025 | |
| Goldman Sachs Group Inc. | 117,00 EUR | +34,01% | 25.04.2025 | |
| Barclays Capital | 125,00 EUR | +43,17% | 24.04.2025 | |
| Bernstein Research | 114,00 EUR | +30,57% | 24.04.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | - |
| Bayer | 1 | 8 | 0 | 25,51 EUR | +2,97% |
| BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +37,43% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 3 | 0 | 9,96 EUR | +42,86% |
| GSK PLC Registered Shs | 2 | 5 | 1 | 16,30 GBP | +8,16% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 165,86 EUR | +42,61% |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +153,50% |
| MorphoSys | 0 | 0 | 0 | - | - |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +6,08% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 28,80 USD | +22,61% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 115,12 EUR | +31,85% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |